For the quarter ending 2026-03-31, NEWTG had $92,725K increase in cash & cash equivalents over the period. -$257,549K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income | 13,401 | 19,541 | 40,971 |
| Net unrealized depreciation (appreciation) on joint ventures and other investments | -2,523 | -3,671 | -734 |
| Net gain (loss) on loans accounted for under the fair value option | -49,578 | 25,591 | 35,566 |
| Net gain on residuals in securitizations | 56,144 | 0 | 30,015 |
| Net loss on loan servicing assets | -6,197 | -4,192 | -12,500 |
| Net unrealized (appreciation) depreciation on warrants and derivative transactions | 249 | 501 | -427 |
| Unrealized loss on assets classified as held for sale | - | 0 | - |
| Net gain on sales of loans | 26,682 | 9,505 | 38,050 |
| Net accretion of premium/discount on debt securities available-for-sale and loans | -400 | -104 | 1,423 |
| Loss on extinguishment of debt, deferred financing costs expensed | - | 0 | -158 |
| Amortization of deferred financing costs and deferred loan fees and costs | 1,420 | 1,171 | 3,225 |
| Provision for credit losses | 9,608 | 8,395 | 30,334 |
| Lower of cost or market adjustment on loans held for sale | 24 | -41 | 53 |
| Bad debt expense, net of recoveries | -107 | 0 | 283 |
| Stock compensation expense | 565 | 89 | 4,008 |
| Deferred income tax (benefit) expense | -16,996 | 5,385 | 3,097 |
| Depreciation and amortization | 36 | 119 | 549 |
| Proceeds from sale of loans held for sale | 118,869 | 94,301 | 310,246 |
| Sale of loans held for sale from affiliate | - | 0 | 0 |
| Purchase of loans held for sale | 22,179 | - | - |
| Funding of loans held for sale | 267,951 | 284,943 | 777,953 |
| Principal received on loans held for sale | 4,707 | 15,853 | 7,275 |
| Principal received on investments | - | 0 | - |
| Other, net | 186 | 104 | 1,145 |
| Settlement receivable | 51,074 | -31 | -51,996 |
| Dividends receivable | - | 0 | - |
| Other assets | 3,856 | 5,007 | 16,097 |
| Assets classified as held for sale | - | 0 | - |
| Liabilities directly associated with assets classified as held for sale | - | 0 | - |
| Dividends payable | - | 0 | - |
| Due to participants | -24,934 | 17,341 | 13,516 |
| Accounts payable, accrued expenses and other liabilities | 5,618 | 4,012 | -6,853 |
| Net cash used in operating activities | -257,460 | -151,405 | -427,836 |
| Principal received on loans held for investment, at fair value | 15,119 | 17,923 | 53,907 |
| Repurchases of loans held for investment, at fair value | 2,987 | 0 | 4,669 |
| Net increase in loans held for investment, at cost | -100,083 | -70,495 | -242,775 |
| Proceeds from sales of biller genie and newtek technology solutions, inc | 1,983 | 0 | 4,000 |
| Asset purchase of controlling interest in ncl jv, net of cash acquired | - | 10,120 | - |
| Contributions to joint ventures and other investments | - | -15,750 | 15,835 |
| Return of capital from joint ventures and other investments | 0 | -5,630 | 5,644 |
| Purchase of fixed assets | 89 | 10 | 96 |
| Sales of federal home loan bank and federal reserve bank stock | -23 | -23 | -338 |
| Purchases of federal home loan bank and federal reserve bank stock | 361 | 193 | 817 |
| Purchases of available-for-sale securities | -8,367 | -8,364 | -11,573 |
| Maturities of available-for-sale securities | 9,500 | 9,700 | 18,000 |
| Acquisitions, net of cash acquired | - | 0 | - |
| Net cash used in investing activities | -85,262 | -51,416 | -193,876 |
| Borrowing on bank notes payable | 9,852 | 141,000 | 390,200 |
| Repayment on bank notes payable | 193,973 | 58,272 | 295,531 |
| Net increase (decrease) in deposits | 439,462 | 239,968 | 204,384 |
| Repayment of federal home loan bank advances | 561 | 513 | 7,513 |
| Proceeds from common shares sold, net of offering costs | - | 1 | 5,090 |
| Proceeds from preferred stock, net of offering costs | - | 0 | 48,181 |
| Securities purchase and exchange agreement | - | 0 | 10,000 |
| Repurchase of common shares under share repurchase plan | - | 1,491 | - |
| Proceeds from notes-A20258125Notes | - | 0 | - |
| Retirement of common shares | - | -167 | 167 |
| Proceeds from notes-A2028Notes | - | 0 | - |
| Proceeds from notes-A20338.375Notes | 15,000 | - | - |
| Redemption of notes-A2024Notes | - | 0 | 0 |
| Redemption of notes-A2026Notes | 87,123 | - | - |
| Redemption of notes-A2025500Notes | 0 | 0 | 30,000 |
| Proceeds from notes-A20298.50Notes | - | 0 | 0 |
| Proceeds from notes-A20298.625Notes | - | 0 | 0 |
| Proceeds from notes-A20308.375Notes | 0 | 2,000 | 30,000 |
| Purchase of 2029 8.50 notes-A20298.50Notes | - | 0 | 67 |
| Payments on notes payable - securitization trusts | 13,287 | 13,733 | 46,671 |
| Proceeds related to residuals in securitizations | 273,074 | 0 | 169,420 |
| Dividends paid, net of dividend reinvestment plan | 6,476 | 11,868 | 16,176 |
| Payments of deferred financing costs | 158 | 122 | 2,934 |
| Proceeds from common stock issued under espp, net of discount | 70 | 78 | 190 |
| Purchase of vested stock for employee payroll tax withholding | 433 | 1,034 | 1,137 |
| Net cash provided by financing activities | 435,447 | 296,181 | 457,269 |
| Net increase (decrease) in cash and restricted cash | 92,725 | 93,360 | -164,443 |
| Cash and restricted cashbeginning of period (note 2) | 310,291 | 164,443 | 381,374 |
| Consolidation/(deconsolidation) of cash and restricted cash from controlled investments related to business combinations and dispositions, net of cash paid | - | 0 | - |
| Cash and restricted cashend of period (note 2) | 403,016 | 93,360 | 216,931 |
NewtekOne, Inc. (NEWTG)
NewtekOne, Inc. (NEWTG)